Gelteq Limited Ordinary Shares (GELS)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.58-0.09%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

$89,296

Net profit

$-1.9M

EPS

$-0.34

EPS estimate

$0.00

Net margin

-2,095.3%

Market cap

$7.5M

Forward P/E

0.0

P/B

0.73

Book value

$0.92

EPS (TTM)

$-0.52

52-week high

$2.01

52-week low

$0.39

50-day MA

$0.60

200-day MA

$0.74

Insiders

47.53%

Institutions

1.03%

Fund	Stake
Wedbush Morgan Securities Inc	0.19%
Citadel Advisors Llc	0.11%
UBS Group AG	0.02%
Private Advisor Group, LLC	0.00%
Two Sigma Investments LLC	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Gelteq Limited Ordinary Shares — free to start.

Data updated 2026-09-18.